Sleep Apnea, Obstructive Completed Phase 3 Trials for Modafinil (DB00745)

IndicationStatusPhase
DBCOND0030275 (Sleep Apnea, Obstructive)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00107848PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea SyndromeTreatment
NCT00107809Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea SyndromeTreatment